3rd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare Disease Initiatives. Priority Review Voucher Reauthorization. Newborn Screening.

LobbyistCovered position, as disclosed
HAYLEY DEMPSEY —
VICTORIA GEMME —
ALLISON HERRITY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Prescription Drug User Fee Act (PDUFA) Reauthorization. PRV Reauthorization. Promising Pathways Act 2.0. Public Law 119-21: One Big Beautiful Bill Act.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
VICTORIA GEMME —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Budget/Appropriations BUD

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. FDA Appropriations.

LobbyistCovered position, as disclosed
VICTORIA GEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.